Burden of breast and gynecological cancers in low-resource countries

Breast and Gynecological Cancers: An Integrated Approach for Screening and Early Diagnosis in Developing Countries

Volumn , Issue , 2013, Pages 1-17

  Sankaranarayanan, R ^a   Ferlay, J ^a  

^a INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84908390580     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-4614-1876-4_1     Document Type: Chapter

References (44)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. GLOBOCAN 2008 v 1.2, cancer incidence and mortality worldwide: lARC CancerBase No. 10 [internet]. Lyon: International Agency for Research on Cancer; 2010. http://globocan.iarc.fr.
2. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer. 2010; 127(12):2893-917.
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55(2): 74-108.
4. Bray F, Ren JS, Masuyer E, Ferlay J. Global estimates of cancer prevalence for 27 sites in the adult population in 2008. Int J Cancer. 2013;132(5):1133-45. doi:10.1002/ijc.27711.
5. Murray CJ, Lopez AD. The incremental effect of ageweighting on YLLs, YLDs, and DALYs: a response. BuU World Health Organ. 1996;74(4):445-6.
6. Murthy NS, Nandakumar BS, Pruthvish S, George PS, Mathew A. Disability adjusted life years for cancer patients in India. Asian Pac J Cancer Prev. 2010;11(3):633-40.
7. Soerjomataram I, Lortet-Tieulent J, Ferlay J, Forman D, Mathers C, Parkin DM, et al. Estimating and validating disability-adjusted life years at the global level: a methodological framework for cancer. BMC Med Res Methodol. 2012;12(1):125.
8. Curado MP, Edwards B, Shin HR, Storm H, Ferlay J, Heanue M, et al. Cancer incidence in five continents, vol. 9. Lyon: International Agency for Research on Cancer; 2007.
9. World Health Organization (WHO) Databank. WHO statistical information system. Geneva: WHO; 2012. http://www.who.int/whosis.
10. Sankaranarayanan R, Swaminathan R, Brenner H, Chen K, Chia KS, Chen JG, et al. Cancer survival in Africa, Asia, and Central America: a population-based study. Lancet Oncol. 2010;11(2):165-73.
11. Sankaranarayanan R, Swaminathan R. Cancer survival in Africa, Asia, the Caribbean and Central America. IARC scientific publications No. 162. Lyon: International Agency for Research on Cancer; 2011.
12. United Nations. Population division. World Population Prospects, the 2008 revision. http://www.un.org.
13. Bray F, McCarron P, Parkin DM. The changing global patterns of female breast cancer incidence and mortality. Breast Cancer Res. 2004;6(6):229-39.
14. Parkin DM, Nambooze S, Wabwire-Mangen F, Wabinga HR. Changing cancer incidence in Kampala, Uganda, 1991-2006. Int J Cancer. 2010;126(5): 1187-95.
15. Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61(2):69-90.
16. Youlden DR, Cramb SM, Dunn NA, Muller JM, Pyke CM, Baade PD. The descriptive epidemiology of female breast cancer: an international comparison of screening, incidence, survival and mortality. Cancer Epidemiol. 2012;36(3):237-48.
17. Guo P, Huang ZL, Yu P, Li K. Trends in cancer mortality in China: an update. Ann Oncol. 2012;23(10): 2755-62.
18. Groot MT, Baltussen R, Uyl-de Groot CA, Anderson BO, Hortobagyi GN. Costs and health effects of breast cancer interventions in epidemiologically different regions of Africa, North America, and Asia. Breast J. 2006;12 Suppl 1:S81-90.
19. International Agency for Research on Cancer. IARC handbooks of cancer prevention, Breast cancer screening, vol. 7. Lyon: IARC Press; 2002.
20. Mittra I, Mishra GA, Singh S, Aranke S, Notani P, Badwe R, et al. A cluster randomized, controlled trial of breast and cervix cancer screening in Mumbai, India: methodology and interim results after three rounds of screening. Int J Cancer. 2010;126(4): 976-84.
21. Sankaranarayanan R, Ramadas K, Thara S, Muwonge R, Prabhakar J, Augustine P, et al. Clinical breast examination: preliminary results from a cluster randomized controlled trial in India. J Natl Cancer Inst. 2011;103(19):1476-80.
22. Zelle SG, Nyarko KM, Bosu WK, Aikins M, Niens LM, Lauer JA, et al. Costs, effects and cost-effectiveness of breast cancer control in Ghana. Trop Med Int Health. 2012;17(8):1031-43.
23. Okonkwo QL, Draisma G, der Kinderen A, Brown ML, de Koning HJ. Breast cancer screening policies in developing countries: a cost-effectiveness analysis for India. J Natl Cancer Inst. 2008;100(18): 1290-300.
24. Bray F, Jemal A, Grey N, Ferlay J, Forman D. Global cancer transitions according to the Human Development Index (2008-2030): a population-based study. Lancet Oncol. 2012;13(8):790-801.
25. Sankaranarayanan R, Budukh AM, Rajkumar R. Effective screening programmes for cervical cancer in low- and middle-income developing countries. Bull World Health Organ. 2001;79(10):954-62.
26. Bosch FX, de Sanjose S. Chapter 1: Human papillomavirus and cervical cancer-burden and assessment of causality. J Natl Cancer Inst Monogr. 2003;31: 3-13.
27. International Agency for Research on Cancer. IARC handbooks of cancer prevention, Cervix cancer screening, vol. 10. Lyon: IARC Press; 2004.
28. Gustafsson L, Ponten J, Bergstrom R, Adami HO. International incidence rates of invasive cervical cancer before cytological screening. Int J Cancer. 1997;71(2):159-65.
29. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med. 2003; 348(6):518-27.
30. International Agency for Research on Cancer. lARC monographs on the evaluation of carcinogenic risks to humans, Human papillomaviruses, vol. 90. Lyon: International Agency for Research on Cancer; 2007.
31. Human papillomavirus vaccines. WHO position paper. Wkly Epidemiol Rec 2009;84(15):118-31.
32. Tsu V, Murray M, Franceschi S. Human papillomavirus vaccination in low-resource countries: lack of evidence to support vaccinating sexually active women. Br J Cancer. 2012;107(9):1445-50. doi:10.1038/bjc.2012.404.
33. Binagwaho A, Wagner CM, Gatera M, Karema C, Nutt CT, Ngabo F. Achieving high coverage in Rwanda&s national human papillomavirus vaccination programme. BuU World Health Organ. 2012;90(8):623-8.
34. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, et al. Cost- effectiveness of cervical-cancer screening in five developing countries. N Engl J Med. 2005;353(20): 2158-68.
35. Denny L, Kuhn L, De SM, Pollack AE, Dupree W, Wright Jr. TC. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: a randomized controlled trial. JAMA. 2005;294(17):2173-81.
36. Denny L, Kuhn L, Hu CC, Tsai WY, Wright Jr. TC. Human papillomavirus-based cervical cancer prevention: long-term results of a randomized screening trial. J Natl Cancer Inst. 2010;102(20):1557-67.
37. Sankaranarayanan R, Esmy PO, Rajkumar R, Muwonge R, Swaminathan R, Shanthakumari S, et al. Effect of visual screening on cervical cancer incidence and mortality in Tamil Nadu, India: a cluster-randomised trial. Lancet. 2007;370(9585):398-406.
38. Sankaranarayanan R, Nene BM, Shastri SS, Jayant K, Muwonge R, Budukh AM, et al. HPV screening for cervical cancer in rural India. N Engl J Med. 2009; 360(14):1385-94.
39. Ginsberg GM, Lauer JA, Zelle S, Baeten S, Baltussen R. Cost effectiveness of strategies to combat breast, cervical, and colorectal cancer in sub-Saharan Africa and South East Asia: mathematical modelling study. BMJ. 2012;344:e614.
40. Yeole BB. Trends in cancer incidence in female breast, cervix uteri, corpus uteri, and ovary in India. Asian Pac J Cancer Prev. 2008;9(1):119-22.
41. Song F, He M, Li H, Qian B, Wei Q, Zhang W, et al. A cancer incidence survey in Tianjin: the third largest city in China-between 1981 and 2000. Cancer Causes Control. 2008;19(5):443-50.
42. Wu QJ, Vogtmann E, Zhang W, Xie L, Yang WS, Tan YT, et al. Cancer incidence among adolescents and young adults in urban Shanghai, 1973-2005. PLoS One. 2012;7(8):e42607.
43. Gentry-Maharaj A, Menon U. Screening for ovarian cancer in the general population. Best Pract Res Clin Obstet Gynaecol. 2012;26(2):243-56.
44. World Health Organization. National cancer control programmes: policies and managerial guidelines. 2nd ed. Geneva: World Health Organization; 2002.